BioLife Solutions Valuation
| BLFS Stock | USD 20.83 0.59 2.75% |
At this time, the firm appears to be undervalued. BioLife Solutions shows a prevailing Real Value of $24.81 per share. The current price of the firm is $20.83. Our model approximates the value of BioLife Solutions from analyzing the firm fundamentals such as Return On Equity of -0.0252, profit margin of (0.12) %, and Current Valuation of 932.38 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that BioLife Solutions' price fluctuation is not too volatile at this time. Calculation of the real value of BioLife Solutions is based on 3 months time horizon. Increasing BioLife Solutions' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BioLife stock is determined by what a typical buyer is willing to pay for full or partial control of BioLife Solutions. Since BioLife Solutions is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BioLife Stock. However, BioLife Solutions' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 20.83 | Real 24.81 | Hype 20.82 | Naive 21.37 |
The intrinsic value of BioLife Solutions' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BioLife Solutions' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BioLife Solutions helps investors to forecast how BioLife stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BioLife Solutions more accurately as focusing exclusively on BioLife Solutions' fundamentals will not take into account other important factors: BioLife Solutions Total Value Analysis
BioLife Solutions is currently forecasted to have valuation of 932.38 M with market capitalization of 1.02 B, debt of 30.17 M, and cash on hands of 46.55 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the BioLife Solutions fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
932.38 M | 1.02 B | 30.17 M | 46.55 M |
BioLife Solutions Investor Information
About 97.0% of the company shares are held by institutions such as insurance companies. The book value of BioLife Solutions was currently reported as 7.42. The company has Price/Earnings (P/E) ratio of 173.59. BioLife Solutions recorded a loss per share of 0.19. The entity had not issued any dividends in recent years. The firm had 1:14 split on the 29th of January 2014. Based on the key indicators related to BioLife Solutions' liquidity, profitability, solvency, and operating efficiency, BioLife Solutions is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.BioLife Solutions Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of BioLife implies not a very effective usage of assets in July.BioLife Solutions Ownership Allocation
The majority of BioLife Solutions outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in BioLife Solutions to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in BioLife Solutions. Please pay attention to any change in the institutional holdings of BioLife Solutions as this could imply that something significant has changed or is about to change at the company.BioLife Solutions Profitability Analysis
The company reported the previous year's revenue of 82.25 M. Net Loss for the year was (20.18 M) with profit before overhead, payroll, taxes, and interest of 57.22 M.About BioLife Solutions Valuation
The stock valuation mechanism determines BioLife Solutions' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of BioLife Solutions based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioLife Solutions. We calculate exposure to BioLife Solutions's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BioLife Solutions's related companies.BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. Biolife Solutions operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 432 people.
BioLife Solutions Growth Indicators
Investing in growth stocks can be very risky. If the company such as BioLife Solutions does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 46.1 M | |
| Quarterly Earnings Growth Y O Y | 6.4 | |
| Forward Price Earnings | 250 |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.